A single centre 20-year retrospective cohort study: Percutaneous endoscopic colostomy.
large bowel obstruction
neurogenic bowel
percutaneous endoscopic colostomy
recurrent sigmoid volvulus
Journal
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
ISSN: 1463-1318
Titre abrégé: Colorectal Dis
Pays: England
ID NLM: 100883611
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
revised:
09
05
2022
received:
01
03
2022
accepted:
24
05
2022
pubmed:
4
6
2022
medline:
29
11
2022
entrez:
3
6
2022
Statut:
ppublish
Résumé
Percutaneous endoscopic colostomy (PEC) represents an important intervention in specific patients. Limited data currently exist. We present the largest recorded study of patients undergoing PEC. Retrospective analysis of consultant logbooks highlighted all patients from 1997 to 2020. Two independent reviewers assessed records. Parameters measured were age, sex, indication, number of sites, complications, mortality and survival. Three subgroups were identified: recurrent sigmoid volvulus (RSV), pseudo-obstruction and neurogenic. ANOVA, chi-squared and Fischer's exact tests were utilized; Kaplan-Meier curves estimated survival and the log-rank test was applied. A p value of <0.05 was considered statistically significant. Ninety-six PEC insertions were done on 91 patients (five reinsertions). There were 66 men (69%) and the mean age was 73.1 years (interquartile range 23). The indications were RSV n = 72, pseudo-obstruction n = 13, neurogenic n = 11. The 30-day complication rate was overall n = 27 (28%), RSV n = 23, pseudo-obstruction n = 4. Nine patients leaked (9.9%) (eight RSV, one pseudo-obstruction), of whom five died. 90-day mortality was 14.6% (14 patients), 18.5% (13/72) for RSV, 7.7% (1/13) for pseudo-obstruction. Overall recurrence following PEC was 10.4%. The median follow-up was 25 months (interquartile range 4.6-62.2 months). At 3, 5 and 10 years survival was 46%, 34% and 26% for RSV, 70%, 55% and 15% for pseudo-obstruction and 91%, 91% and 81% for neurogenic respectively. Recurrent sigmoid volvulus and pseudo-obstruction patients undergoing PEC compared to neurogenic patients have poorer outcomes with higher complication rates and shorter life expectancy. We advocate that high volume specialist units undertake PEC. The significant associated risks of PEC require careful consideration when determining patient suitability. Utilizing risk stratification scores may help guide shared decision making between patients, relatives and clinicians.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1390-1396Informations de copyright
© 2022 Association of Coloproctology of Great Britain and Ireland.
Références
NICE Guideline. Percutaneous endoscopic colostomy Interventional procedures guidance. IPG161, NICE; 2006.
Tun G, Bullas D, Bannaga A, Said EM. Percutaneous endoscopic colostomy: a useful technique when surgery is not an option. Ann Gastroenterol. 2016;29(4):477.
Daniels IR, Lamparelli MJ, Chave H, Simson JNL. Recurrent sigmoid volvulus treated by percutaneous endoscopic colostomy. J Br Surg. 2000;87(10):1419.
Heriot AG, Tilney HS, Simson JNL. The application of percutaneous endoscopic colostomy to the management of obstructed defecation. Dis Colon Rectum. 2002;45(5):700-2.
Baraza W, Brown S, McAlindon M, Hurlstone P. Prospective analysis of percutaneous endoscopic colostomy at a tertiary referral centre. J Br Surg. 2007;94(11):1415-20.
Cowlam S, Watson C, Elltringham M, Bain I, Barrett P, Green S, et al. Percutaneous endoscopic colostomy of the left side of the colon. Gastrointest Endosc. 2007;65(7):1007-14.
Frank L, Moran A, Beaton C. Use of percutaneous endoscopic colostomy (PEC) to treat sigmoid volvulus: a systematic review. Endosc Int Open. 2016;4(07):E737-41.
Jackson S, Hamed MO, Shabbir J. Management of sigmoid volvulus using percutaneous endoscopic colostomy. Ann R Coll Surg Engl. 2020;102(9):654-62.
Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187-96.
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ. 2007;85:867-72.
Halabi WJ, Jafari MD, Kang CY, Nguyen VQ, Carmichael JC, Mills S, et al. Colonic volvulus in the United States: trends, outcomes, and predictors of mortality. Ann Surg. 2014;259(2):293-301.